NCT07485166 2026-03-20
Emulation of the CheckMate 017/057 (NCT01642004 and NCT01673867) Trials Using Specialty Oncology Electronic Health Records Databases
Brigham and Women's Hospital
Active not recruiting
Clinical Trials
6 trialsNCT06416410 2025-04-04
JAB-21822 Combined With JAB-3312 Compared SOC in the First Line for Treatment of Advanced Non-small Cell Lung Cancer With KRAS p.G12C Mutation
Allist Pharmaceuticals, Inc.
Phase 3 Recruiting
NCT03190239 2024-02-28
XQonc-007
Xinqiao Hospital of Chongqing
Phase 2 Withdrawn
NCT03792503 2024-02-28
Pemetrexed Plus Apatinib Maintenance Treatment in Patients With Non-squamous Non-small Cell Lung Cancer Patients Who Have Not Progressed After 4 Cycles of Induction Chemotherapy of Pemetrexed in Combination With Platinum-based Regimen
Xinqiao Hospital of Chongqing
Phase 4 Withdrawn
NCT06028633 2023-09-13
Efficacy and Safety of Nab-paclitaxel-Lenvatinib-Pembrolizumab as Second-line Treatment in Advanced NSCLC Patients
Peking University First Hospital
Phase 2 Not yet recruiting
NCT04416035 2020-08-31
NSCLC
Zhejiang Teruisi Pharmaceutical Inc.
Phase 3 Unknown